D.H.E. 45 Drug Patent Profile
✉ Email this page to a colleague
When do D.h.e. 45 patents expire, and what generic alternatives are available?
D.h.e. 45 is a drug marketed by Bausch and is included in one NDA.
The generic ingredient in D.H.E. 45 is dihydroergotamine mesylate. There are six drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the dihydroergotamine mesylate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for D.h.e. 45
A generic version of D.H.E. 45 was approved as dihydroergotamine mesylate by PADAGIS US on April 28th, 2003.
Summary for D.H.E. 45
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 48 |
Patent Applications: | 1,250 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in D.H.E. 45? | D.H.E. 45 excipients list |
DailyMed Link: | D.H.E. 45 at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for D.H.E. 45
US Patents and Regulatory Information for D.H.E. 45
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bausch | D.H.E. 45 | dihydroergotamine mesylate | INJECTABLE;INJECTION | 005929-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |